CHRN vs NBIS: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CHRN and NBIS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CHRN and NBIS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

ChronoScale Corporation is a "neocloud," meaning it buys large clusters of NVIDIA GPUs, installs them in data centers, and rents that accelerated compute to companies running artificial intelligence workloads such as model training, inference, and high-performance computing. It began life as the cloud unit of Applied Digital, a data-center developer, and became a separate public company on May 5, 2026, when that cloud business was combined with the former shell of Ekso Bionics Holdings, which then renamed itself ChronoScale and kept the ticker CHRN on the Nasdaq Capital Market. The company is based in Dallas, Texas. In fiscal 2025 (the year ended May 2025) the cloud unit ran about 6,144 GPUs and generated roughly $84 million of revenue, up about 191% year over year, while posting a net loss of about $73 million as it invested to scale.

Full CHRN guide

Nebius Group is an AI infrastructure company that builds and operates cloud platforms optimized for training and running artificial-intelligence models. It emerged from the international assets of the former Yandex business after Yandex's Russian operations were divested, and it relisted on Nasdaq as a standalone company headquartered in Amsterdam. Nebius's core business is an AI-focused cloud: it builds data centers packed with NVIDIA GPUs and rents that compute capacity to companies training large AI models, competing with the GPU-cloud and neocloud providers that have grown alongside the AI boom. The company designs its own server hardware and software stack to deliver high-performance, cost-efficient AI compute. Beyond the core cloud, Nebius holds several other technology businesses, including an autonomous-driving unit, an edtech platform, and a generative-AI data-labeling business, plus a stake in a data-center and other ventures. As a relatively young public company, Nebius is in a heavy-investment phase, spending aggressively on GPU capacity and data centers to capture AI-infrastructure demand, and is not yet consistently profitable.

Full NBIS guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CHRN drivers: Riding AI compute demand; Independence and capital flexibility.
• NBIS drivers: AI compute demand tailwind; Vertically integrated, cost-efficient stack.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The risks are substantial and stack together. For NBIS, nebius is an early-stage, capital-intensive business: building GPU data centers requires enormous upfront spending, and the company is not yet consistently profitable, with free cash flow deeply negative during the build-out.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CHRN if you believe its drivers more; NBIS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CHRN and NBIS guides.

CHRN. Figures are approximate and tied to the asOf date; verify live numbers before acting. ChronoScale has no meaningful earnings multiple because it loses money, so the market is valuing it on future AI compute growth rather than current profit. The stock has been very volatile since its May 2026 listing, and the roughly 97% parent ownership means the small public float can amplify price swings in either direction.

NBIS. Nebius trades as a speculative, high-growth AI-infrastructure stock valued on future capacity and revenue rather than current earnings. The valuation is highly sensitive to AI-compute demand, GPU access, and execution on data-center build-out. As a young company with negative free cash flow and a complex history, the stock carries large swings tied to AI-infrastructure sentiment and capacity announcements.

Headline figures (approximate, July 2026): CHRN shows revenue (fiscal 2025, ended may 2025) ~$84 million, up roughly 191% year over year, net income (fiscal 2025) ~-$73 million (net loss), gpus deployed (fiscal 2025) ~6,144 GPUs, applied digital ownership ~97% of shares outstanding; NBIS shows revenue (annualized run-rate) ~$1 billion+ and growing rapidly, off a small base, revenue growth Very high, multiple-fold year over year as capacity scales, profitability Not consistently profitable; heavy investment phase, free cash flow Deeply negative during GPU and data-center build-out.

CHRN and NBIS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CHRN and NBIS exposure against your real portfolio. It is not an investment adviser.